DAVITA INC. Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2012-01-31)
DAVITA INC. (DVA) reported Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2012-01-31) of $6.19 million for the 12-month period ending 2011-12-31, per its 8-K filed 2012-07-06.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeTax · last filed 2012-07-06
- DAVITA INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2012-01-31) for fiscal 2008 was $1.65M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-12-31 | $6.19M 8-K · filed 2012-07-06 |
| 2010-12-31 | $3.54M 8-K · filed 2012-07-06 |
| 2009-12-31 | $6.71M 8-K · filed 2012-07-06 |
| 2008-12-31 | $1.65M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |